Antibody-drug conjugates remain front and centre of the biopharma world. Following Enhertu’s historic agnostic approval in HER2-positive solid tumours and TIVDAK winning full approval, the field has ...
GSK has turned to China’s Hansoh Pharma to add another antibody-drug conjugate (ADC) to its oncology pipeline, this time licensing a B7-H3-targeting candidate for $185 million upfront. The new deal – ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. David Kindness is a Certified Public ...
Arthur Pinkasovitch, CFA, has worked 5+ years as a financial analyst. He is an associate director at ATB Financial. David Kindness is a Certified Public Accountant (CPA) and an expert in the fields of ...
Although some major corporations have recently scaled back the diversity, equity and inclusion (DEI) initiatives they once prioritized, DEI remains an important business component for many small and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results